CA Stock MarketDetailed Quotes
NARA PanGenomic Health Inc
- 0.065
- +0.015+30.00%
15min DelayTrading Sep 30 09:30 ET
2.08MMarket Cap-22P/E (TTM)
0.065High0.065Low2.39KVolume0.065Open0.050Pre Close155.03Turnover0.40052wk High0.01%Turnover Ratio32.00MShares0.02552wk Low-2.9EPS TTM1.98MFloat Cap3.650Historical HighLossP/E (Static)30.48MShs Float0.025Historical Low-3EPS LYR0.00%Amplitude--Dividend TTM-1.41P/B1Lot Size--Div YieldTTM
PanGenomic Health Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 83.75%-59.53K | 102.09%15.59K | 43.65%-1.57M | 6.04%-341.21K | 90.70%-113.86K | 36.49%-366.41K | -20.79%-746.59K | -162.69%-2.78M | 53.11%-363.15K | -1,029.16%-1.22M |
| Net income from continuing operations | -164.40%-2.54M | 79.33%-218.75K | 75.21%-2.97M | 94.10%-552.87K | 59.98%-400.38K | -19.02%-961.44K | -28.84%-1.06M | -352.73%-11.99M | -291.63%-9.36M | -1,000.06%-1M |
| Operating gains losses | ---- | ---- | -1,491.29%-36.35K | -7,202.30%-37.07K | 95.23%-108 | 176.38%734 | -75.42%103 | ---2.28K | --522 | ---2.26K |
| Depreciation and amortization | 0.00%3.13K | 3.47%3.13K | 11.60%12.4K | 5.29%3.13K | 7.94%3.13K | 14.93%3.13K | 19.64%3.02K | 422.47%11.11K | 39.63%2.97K | --2.9K |
| Asset impairment expenditure | ---- | ---- | -99.02%82.04K | -99.55%37.34K | --8.46K | ---- | ---- | 366.05%8.36M | --8.36M | --0 |
| Remuneration paid in stock | -60.88%34.07K | -36.90%38.88K | -73.04%166.3K | -54.74%90.37K | -133.86%-72.77K | 29.77%87.09K | -54.40%61.61K | 1,112.31%616.79K | 416.91%199.67K | 8,301.06%214.9K |
| Change In working capital | -67.21%153.4K | -22.10%192.34K | 424.52%1.18M | -52.10%209.47K | 158.31%256.23K | 188.89%467.86K | 278.79%246.9K | 186.90%225.05K | 300.59%437.32K | -2,092.59%-439.4K |
| -Change in receivables | -100.15%-61 | -137.43%-1.61K | 171.26%66.73K | 348.20%24.92K | 86.62%-4.49K | 284.32%42.01K | 115.74%4.29K | -125.18%-93.64K | 54.04%-10.04K | -200.60%-33.56K |
| -Change in prepaid assets | -97.54%3.03K | 130.82%3.16K | 159.33%197.91K | -82.34%31.75K | 125.74%53.12K | 127.22%123.29K | -121.07%-10.24K | 127.80%76.32K | 172.04%179.77K | -725.32%-206.33K |
| -Change in payables and accrued expense | -50.28%150.43K | -24.55%190.79K | 277.85%915.82K | -42.90%152.8K | 204.06%207.6K | 131.89%302.56K | 477.00%252.86K | 324.03%242.38K | 401.41%267.59K | -1,337.42%-199.51K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 83.75%-59.53K | 102.09%15.59K | 43.65%-1.57M | 6.04%-341.21K | 90.70%-113.86K | 36.49%-366.41K | -20.79%-746.59K | -162.69%-2.78M | 53.11%-363.15K | -1,029.16%-1.22M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 93.97%-3.14K | 0 | 0 | 0 | -109.61%-3.14K | 91.38%-52.13K | -839.77%-46.12K | 99.27%-2.56K |
| Net PPE purchase and sale | --0 | --0 | 47.68%-3.14K | --0 | --0 | --0 | -109.61%-3.14K | 11.87%-6.01K | --0 | ---2.56K |
| Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -237.49%-46.12K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 93.97%-3.14K | --0 | --0 | --0 | -109.61%-3.14K | 91.38%-52.13K | -839.77%-46.12K | 99.27%-2.56K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -87.06%45.28K | 0 | -5.04%1.5M | -27.35%341.22K | 126.4K | -68.32%350K | 677.62K | -47.06%1.57M | 931.97%469.68K | 0 |
| Net issuance payments of debt | -86.57%47K | --0 | 581.94%964.4K | 146.59%448.92K | -88.56%126.4K | --350K | --39.08K | 607.11%141.42K | ---963.48K | --1.1M |
| Net common stock issuance | ---1.72K | --0 | -84.22%203.62K | -108.34%-107.7K | --0 | --0 | --311.32K | -47.47%1.29M | 71,132.36%1.29M | -165.52%-1.1M |
| Proceeds from stock option exercised by employees | --0 | --0 | 129.63%327.22K | --0 | --0 | --0 | --327.22K | --142.5K | --142.5K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -87.06%45.28K | --0 | -5.04%1.5M | -27.35%341.22K | --126.4K | -68.32%350K | --677.62K | -47.06%1.57M | 931.97%469.68K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 71.49%28.15K | -85.81%12.56K | -93.44%88.53K | -55.39%12.54K | -100.00%5 | -97.75%16.41K | -93.44%88.53K | 3,427.93%1.35M | -98.65%28.12K | 210.24%1.26M |
| Current changes in cash | 13.18%-14.25K | 121.62%15.59K | 93.97%-75.97K | -99.97%17 | 101.02%12.54K | -103.12%-16.41K | 88.36%-72.11K | -196.16%-1.26M | 108.23%60.41K | -173.12%-1.23M |
| End cash Position | 277,940.00%13.9K | 71.49%28.15K | -85.81%12.56K | -85.81%12.56K | -55.39%12.54K | -100.00%5 | -97.75%16.41K | -93.44%88.53K | -93.44%88.53K | -98.65%28.12K |
| Free cash from | 83.75%-59.53K | 102.08%15.59K | 43.66%-1.57M | 6.04%-341.21K | 90.72%-113.86K | 36.71%-366.41K | -21.00%-749.73K | -161.58%-2.79M | 53.52%-363.15K | -1,031.52%-1.23M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data